Democratizing hedge fund level analysis tools for everyone
| Name | Merck Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Merck Holding Gmbh | 74.0 | 74.0 |
| Emedia Export Company Mbh | 13.0 | 13.0 |
| Public < 5% | 13.0 | 13.0 |
| Source | 2022 | 2021 |
|---|---|---|
| 1513 | MERK | F2 |
| 1514 | MERK | F2 |
| 1515 | MERK | F2 |
| 1516 | MERK | F2 |
| 1517 | MERK | F2 |
| Region | 2022 | 2021 |
|---|---|---|
| 922 | MERK | F2 |
| 923 | MERK | F2 |
| 924 | MERK | F2 |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 1.31 | # 9 / 15 |
| EV_EBITDA | 7.73 | # 4 / 15 |
| PER | 10.47 | # 6 / 15 |
| PBV | 1.66 | # 7 / 15 |
| DER | 0.19 | # 2 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 12.540999999999999 | # 3 / 15 |
| ROA % | 13.780000000000001 | # 3 / 15 |
| ROE % | 15.85 | # 6 / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2024 | 320.0 | 8.9 |
| 2023 | 320.0 | 7.7 |
| 2022 | 240.0 | 5.1 |
| 2021 | 122.0 | 3.3 |
| 2020 | 130.0 | 4.0 |
| 2018 | 2825.0 | 99.1 |
| Timeframe | Performance |
|---|---|
| 1W % | 1.0 |
| 1Mo % | -5.1 |
| 3Mo % | 2.3 |
| 1Yr % | -5.3 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 14.94 | 52.43 T | 53.67 T | 34,651 B | 5,348 B | 3,508 B |
| SOHO | 57.58 | 33.76 T | 36.00 T | 10,566 B | 742 B | 587 B |
| SIDO | 14.43 | 15.75 T | 15.31 T | 3,639 B | 1,481 B | 1,091 B |
| TSPC | 8.35 | 12.67 T | 11.15 T | 13,512 B | 2,016 B | 1,515 B |
| PYFA | -9.55 | 4.67 T | 10.70 T | 2,747 B | -142 B | -488 B |
| MDLA | 8.92 | 3.45 T | 6.04 T | 14,788 B | 557 B | 386 B |